Colgate-Palmolive price target raised to $100 from $90 at BofA

BofA raised the firm’s price target on Colgate-Palmolive (CL) to $100 from $90 and keeps a Buy rating on the shares. Colgate-Palmolive exited Q4 with clear momentum and appears to carry reasonable topline and bottom-line flexibility into 2026, the analyst tells investors. The analyst, who sees a path to improved organic sales performance throughout the year, adds that Colgate-Palmolive remains a top pick for 2026 “both within our HPC coverage and Consumer Staples broadly.”